|
|
||||||||
Animal: RNA Viruses |
Institute for Animal Health, Compton, Newbury, Berkshire RG20 7NN , UK1
Centro Nacional de Biologia Fundamental, Instituto de Salud Carlos III, Majadahonda, 28220 Madrid, Spain2
NIBSC, Blanche Lane, South Mimms, Potters Bar, Hertfordshire EN6 3QG, UK3
Author for correspondence: Gary Bembridge. Fax +44 1635 577263. e-mail Gary.Bembridge{at}bbsrc.ac.uk
Significant protection against respiratory syncytial virus (RSV) infection was induced in mice vaccinated intramuscularly (i.m.) with DNA encoding the F or G protein of RSV. The amounts of IgG1 of IgG2a antibodies in mice immunized with DNA-G alone were similar. However, the antibody response in mice co-immunized with DNA-G and DNA encoding IL-4 (DNA-IL-4) was strongly biased towards IgG1. In contrast, the antibody response in mice co-immunized with DNA-G and DNA-IL-2, -IL-12 or-IFN-
was biased towards IgG2a. Mice vaccinated with DNA-F either alone or in combination with DNA encoding cytokines developed a predominant RSV-specific IgG2a response, which was most pronounced in mice co-immunized with DNA-F and DNA-IL-12 or -IFN-
. Vaccinated mice developed only a slightly enhanced pulmonary inflammatory response following RSV challenge. More significantly, and in contrast to mice scarified with recombinant vaccinia virus expressing the G protein, mice vaccinated i.m. with DNA-G did not develop pulmonary eosinophilia, even when the immune response was biased towards a Th2 response by co-administration of DNA-IL-4.
This article has been cited by other articles:
![]() |
R. Kohlmann, S. Schwannecke, B. Tippler, N. Ternette, V. V. Temchura, M. Tenbusch, K. Uberla, and T. Grunwald Protective Efficacy and Immunogenicity of an Adenoviral Vector Vaccine Encoding the Codon-Optimized F Protein of Respiratory Syncytial Virus J. Virol., December 1, 2009; 83(23): 12601 - 12610. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Johnstone, S. Guil, M. A. Rico, B. Garcia-Barreno, D. Lopez, J. A. Melero, and M. Del Val Relevance of viral context and diversity of antigen-processing routes for respiratory syncytial virus cytotoxic T-lymphocyte epitopes J. Gen. Virol., September 1, 2008; 89(9): 2194 - 2203. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Boxus, M. Tignon, S. Roels, J.-F. Toussaint, K. Walravens, M.-A. Benoit, P. Coppe, J.-J. Letesson, C. Letellier, and P. Kerkhofs DNA Immunization with Plasmids Encoding Fusion and Nucleocapsid Proteins of Bovine Respiratory Syncytial Virus Induces a Strong Cell-Mediated Immunity and Protects Calves against Challenge J. Virol., July 1, 2007; 81(13): 6879 - 6889. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Cseke, D. W. Wright, S. J. Tollefson, J. E. Johnson, J. E. Crowe Jr., and J. V. Williams Human Metapneumovirus Fusion Protein Vaccines That Are Immunogenic and Protective in Cotton Rats J. Virol., January 15, 2007; 81(2): 698 - 707. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. M. Openshaw and J. S. Tregoning Immune Responses and Disease Enhancement during Respiratory Syncytial Virus Infection Clin. Microbiol. Rev., July 1, 2005; 18(3): 541 - 555. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Johnstone, P. de Leon, F. Medina, J. A. Melero, B. Garcia-Barreno, and M. D. Val Shifting immunodominance pattern of two cytotoxic T-lymphocyte epitopes in the F glycoprotein of the Long strain of respiratory syncytial virus J. Gen. Virol., November 1, 2004; 85(11): 3229 - 3238. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Schlender, G. Walliser, J. Fricke, and K.-K. Conzelmann Respiratory Syncytial Virus Fusion Protein Mediates Inhibition of Mitogen-Induced T-Cell Proliferation by Contact J. Virol., February 1, 2002; 76(3): 1163 - 1170. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |